Alcon Slapped With Untitled Letter, FDA: Rebate Card Used Incorrectly

Washington Drug Letter
A A
The FDA has sent an untitled letter to Novartis subsidiary Alcon Research for a rebate card that the company wrongly treated as reminder labeling.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00